John Crowley, Chief Executive Officer & Chairman of Amicus Therapeutics, presented at last year's World Orphan Drug Congress USA on the topic âRare diseases 2020: A vision for the next decade.'
Do you want to learn more about:
- A new framework for market incentives
- Appropriate public private partnerships in the ultra-orphans
- Moving from 300 to 3,000 diseases treated
- Building a community
- Toward Orphan Drug Act II
If so, you need to check out the video below:
For more information on orphan drugs and rare diseases, check out the World Orphan Drug Congress USA. Remember, the earlier you book, the more you save, so register now to secure your seat!